Cancer biologic therapy studies
Cancer biologic therapy trials, on your terms
It begins with one short conversation, which costs nothing and carries no obligation. Cancer Biologic Trials is here to help you, or someone you are caring for, learn about cancer biologic therapy trials, and to connect you with a study team if you are interested.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed

Cancer biologic therapy studies in numbers
- cancer biologic therapy studies recruiting in the U.S.
- 445
- states with a study site
- 51
- cities with a study site
- 1,188
- studies that accept healthy volunteers
- 8
Source: ClinicalTrials.gov. Data processed .
Find cancer biologic therapy studies near you
These states have the most studies recruiting right now.
California
185 studies recruiting.
Texas
140 studies recruiting.
New York
134 studies recruiting.
Florida
126 studies recruiting.
Ohio
111 studies recruiting.
All locations
Browse every state and city with a recruiting study.
Cancer biologic therapy studies recruiting now
As of November 18, 2026, 445 cancer biologic therapy studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry. This is what they have in common.
What they test
- biologics such as vaccines or antibodies425
- medications269
- procedures173
- other approaches79
- radiation33
A study can test more than one.
Main purpose
- treating a condition415
- diagnosis3
- other purposes3
- prevention3
Phase
- Early Phase 18
- Phase 1133
- Phase 1/274
- Phase 2154
- Phase 2/36
- Phase 351
- Phase 42
- No phase3
- Observational14
Studies of devices and behavioral approaches have no phase.
Who runs them
- university, hospital or other256
- industry139
- government50
Who they enroll
- adults (18 to 64)441
- older adults (65 and over)419
- mainly children and teens (under 18)14
8 also accept healthy volunteers.
Where: sites in 51 states. The cities with the most are Houston, TX (101), New York, NY (99), Duarte, CA (77), Seattle, WA (74), Los Angeles, CA (73), Chicago, IL (72), St Louis, MO (67), Columbus, OH (65).
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 445 studies.
Recruiting now, by research area
- Breast Cancer: 73 studies recruiting in the United States.
- Lung Cancer: 121 studies recruiting in the United States.
- Prostate Cancer: 28 studies recruiting in the United States.
- Melanoma: 48 studies recruiting in the United States.
- Lymphoma: 204 studies recruiting in the United States.
- Pancreatic Cancer: 32 studies recruiting in the United States.
Recently updated cancer biologic therapy studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Aurora, CO · Aventura, FL · Baltimore, MD · and 16 more U.S. locations
- Registry record
- NCT03606967 · updated
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Ankeny, IA · Ann Arbor, MI · Atlanta, GA · and 66 more U.S. locations
- Registry record
- NCT03739814 · updated
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Allentown, PA · Ames, IA · Anaconda, MT · and 170 more U.S. locations
- Registry record
- NCT03866382 · updated
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Albuquerque, NM · Alexandria, VA · Ames, IA · and 163 more U.S. locations
- Registry record
- NCT05136196 · updated
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Chicago, IL · Duarte, CA · Mineola, NY · and 5 more U.S. locations
- Registry record
- NCT05272384 · updated
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Boston, MA · Chicago, IL · Columbus, OH · and 9 more U.S. locations
- Registry record
- NCT05372614 · updated
Source: ClinicalTrials.gov. Data processed .
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.
Cancer Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Not sure which study fits?
Tell a coordinator what you are looking for. They will explain which cancer biologic therapy studies may be worth a closer look and what the next step is. Asking does not commit you to anything.
How taking part works
There are four steps here. At each one, you are the person who decides whether to go on to the next.
Tell us what you are looking for
Pick up the phone or fill in a short form, then tell us which cancer or which kind of biologic study you have in mind.
Talk with a coordinator
You hear from a coordinator, who goes over the studies that may be a match and gives plain-language answers to whatever you ask.
Meet the study team
Carry on only if you want to. The team running the cancer biologic trial then explains it to you piece by piece and looks at whether you meet its entry requirements.
Decide what is right for you
Whether to take part is your choice, always. For any reason and at any point, you are free to change your mind and leave a study.
Research areas
The areas below are where we help you, or a loved one, look into cancer biologic therapy trials.
Breast Cancer studies
Breast cancer biologic therapy studies: find out which ones are recruiting right now and where they are running.
Lung Cancer studies
Look up the lung cancer biologic therapy studies that are currently recruiting, along with their locations.
Prostate Cancer studies
For prostate cancer, check which biologic therapy studies are open for recruitment today and where each one is.
Melanoma studies
Melanoma biologic therapy studies recruiting at the moment are shown here, with the places they are being run.
Lymphoma studies
Find the lymphoma biologic therapy studies that are recruiting now, and see where each is located.
Pancreatic Cancer studies
Here you can see which pancreatic cancer biologic therapy studies are recruiting now, and where each one is.
Not sure where you fit?
Describe the kind of cancer biologic trial you or your family member have in mind. One of our coordinators will suggest where to look next.
Why people take part in cancer biologic therapy studies
The reasons people give for joining a cancer biologic therapy trial vary, and each of them is worth talking through before you or your family member decides.
- Some want a research team to follow their health closely while the study is running.
- Some hope to understand more about the cancer they are living with.
- Some want to help researchers answer questions, and those answers may shape care for other people later on.
Keep in mind that a study is research. It is not treatment, and nobody is able to promise that you personally will be helped by taking part. For a plain explanation, read what a clinical trial is.
Your safety and your rights come first
No cancer biologic trial can enroll a single person until an independent ethics committee has reviewed it. You will also have the details in written form before anyone asks you to agree to a thing. From here you can read up on informed consent, see the way a study is reviewed and monitored, and check the rights you keep for as long as you take part.
Common questions about cancer biologic therapy studies
Does it cost anything to ask about a study?
No. A conversation with Cancer Biologic Trials costs you nothing. Asking questions also does not sign you up for anything.
Do I have to take part if I call?
No. Whether to continue is your decision at each step, and stopping is allowed at any time.
Who decides whether I can join a study?
Only the study team can say, and only once your screening visit is done. Each cancer biologic trial sets requirements of its own. See how screening works.
Ask about cancer biologic therapy studies
Tell us a little about yourself, or about the person you're helping, and a coordinator will be in touch. Asking about a cancer biologic trial commits you to nothing.
Learn more from independent sources
- What Are Clinical Trials and Studies? — National Institute on Aging (NIH)
- About Research Participation — HHS Office for Human Research Protections
- Learn About Studies — ClinicalTrials.gov (National Library of Medicine)